Inova Schar Cancer Institute — Fairfax, Virginia

Inova Schar Cancer Institute is a clinical research site located in Fairfax, Virginia, United States 22031.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

Inova Schar Cancer Institute has participated in 219 clinical trials with 136 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Microsatellite Stable Metastatic Colorectal Cancer, Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8.

Sponsors: Genmab, University of Colorado, Denver, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairfax

Browse all research sites in Virginia · View every site in Fairfax

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Inova Schar Cancer Institute?

Inova Schar Cancer Institute has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Inova Schar Cancer Institute conducted?

Inova Schar Cancer Institute has 219 clinical trials on record, with 136 currently active. Their work covers Platinum-resistant Ovarian Cancer, Microsatellite Stable Metastatic Colorectal Cancer, Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8.

Is Inova Schar Cancer Institute accredited by Crixeo Clinical Trials?

Inova Schar Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Inova Schar Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.